Knight Therapeutics Announces Regulatory Submission of Pemigatinib in Brazil Pharmaceutical Investing
Salix Pharmaceuticals Releases Liver Health Annual Trends Report Identifying Increase in Chronic Liver Disease and Cirrhosis-Related Deaths Marking These as Ninth Leading Cause of Death in U.S. Pharmaceutical Investing
Cardiol Therapeutics Announces Positive Study Results Demonstrating Cardioprotective Effects of Subcutaneously Administered Cannabidiol in a Model of Heart Failure with Preserved Ejection Fraction Geography
BriaCell Partners with New York Cancer & Blood Specialists for Pivotal Phase 3 Study of Bria-IMT in Advanced Breast Cancer Geography
Knight Therapeutics Inc. places No. 90 on The Globe and Mail's fifth-annual ranking of Canada's Top Growing Companies Pharmaceutical Investing
Bausch Health's Bausch + Lomb Announces Completion of the Acquisition of XIIDRA Pharmaceutical Investing
League of United Latin American Citizens Joins OraPharma in the Fight Against Gum Disease Pharmaceutical Investing
